eBay Inc. (NASDAQ:EBAY) will release its financial results for the second quarter of 2014 after the market close on Wednesday, July 16, 2014. The company will host a conference call for investors and analysts to discuss financial results for the quarter at 2 p.m. Pacific/5:00 p.m. Eastern. eBay Inc (NASDAQ:EBAY) stock performance was -0.67 in last session and finished the day at $50.81. Traded volume was 9.44million shares in the last session and the average volume of the stock remained 12.07million shares. The beta of the stock remained 1.06. eBay Inc (NASDAQ:EBAY) insider ownership is 8.80%.
Zacks reaffirmed their neutral rating on shares of The Progressive Corp (NYSE:PGR) in a report issued on Monday. They currently have a $26.00 target price on the stock. The Progressive Corporation (NYSE:PGR) dropped -0.04 percent to $24.40 Tuesday on volume of 4.92million shares. The intra-day range of the stock was $24.29 to $24.68. The Progressive Corporation (NYSE:PGR) has a market capitalization of $14.43billion.
The Boeing Company (NYSE:BA) is teaming up with Blue Origin, Masten is working with XCOR Aerospace and Northrop Grumman is working with the company Virgin Galactic, which is building its own private suborbital spaceliner for space tourist trips, DARPA officials said. The Boeing Company (NYSE:BA) already provides one robotic space plane to the U.S. military; the company builds a vehicle called the X-37B for the Air Force. One X-37B spacecraft has been circling Earth on a secret military mission since December 2012. The company representatives said that the company’s preliminary XS-1 contract is worth $4 million. The Boeing Company (NYSE:BA)’s stock on July 15, 2014 reported a decrease of -0.32% to the closing price of $129.10. Its fifty two weeks range is $101.77 -$144.57. The total market capitalization recorded $94.14billion. The overall volume in the last trading session was 4.92million shares. In its share capital, BA has 729.22million outstanding shares.
The nation’s largest pharmacy benefit manager, Express Scripts Holding Company (NASDAQ:ESRX), is dramatically scaling back its coverage of compounded medications, saying most of the custom-mixed medicines are ineffective or overpriced. On Tuesday, shares of Express Scripts Holding Company (NASDAQ:ESRX) advanced 0.25% to close the day at $68.07. Company return on investment (ROI) is 6.80% and its monthly performance is recorded as -4.92%. Express Scripts Holding Company (NASDAQ:ESRX) quarterly revenue growth is -5.77%.